0001104659-21-053237.txt : 20210421 0001104659-21-053237.hdr.sgml : 20210421 20210421171657 ACCESSION NUMBER: 0001104659-21-053237 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210419 FILED AS OF DATE: 20210421 DATE AS OF CHANGE: 20210421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SQUINTO STEPHEN P CENTRAL INDEX KEY: 0001231954 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38807 FILM NUMBER: 21842476 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd. CENTRAL INDEX KEY: 0001534248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV STATE: L3 ZIP: 6158002 BUSINESS PHONE: 972-77-331-0156 MAIL ADDRESS: STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV STATE: L3 ZIP: 6158002 FORMER COMPANY: FORMER CONFORMED NAME: Anchiano Therapeutics Ltd. DATE OF NAME CHANGE: 20180906 FORMER COMPANY: FORMER CONFORMED NAME: BioCancell Ltd. DATE OF NAME CHANGE: 20111104 4 1 tm2113689d6_4.xml FORM 4 X0306 4 2021-04-19 0 0001534248 Chemomab Therapeutics Ltd. CMMB 0001231954 SQUINTO STEPHEN P 930 5TH AVE, APT 18A NEW YORK NY 10021 1 0 0 0 American Depositary Shares 47938 D Option to Purchase American Depositary Shares 27.26 2021-04-19 4 A 0 23768 0 A 2031-04-19 American Depositary Shares 23768 23768 D Option to Purchase American Depositary Shares 0.67 2025-11-18 American Depositary Shares 424 424 D Option to Purchase American Depositary Shares 0.8 2026-09-13 American Depositary Shares 2109 2109 D Option to Purchase American Depositary Shares 1.49 2027-11-19 American Depositary Shares 21095 21095 D Option to Purchase American Depositary Shares 1.49 2028-10-21 American Depositary Shares 32928 32928 D Option to Purchase American Depositary Shares 1.48 2030-11-19 American Depositary Shares 40362 40362 D No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service. These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service. 14,059 of these options to purchase ADSs have vested and are exercisable as of the date hereof, while the remaining 7,036 of these options will vest and become exercisable in three installments, with 1/3 of the options vesting on each three month anniversary commencing on May 16, 2021, subject to the Reporting Person's continued service. 5,042 of these options to purchase ADSs have vested and are exercisable as of the date hereof, while the remaining 35,320 of these options will vest and become exercisable in seven installments, with 1/7 of the options vesting on each three month anniversary commencing on May 19, 2021, subject to the Reporting Person's continued service. /s/ Matthew Rudolph, Esq., Attorney-in-Fact for Stephen Squinto 2021-04-21